Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal mesothelioma: Preliminary results and survival analysis

Surgical Oncology

Volumn 24, Issue 1, 2015, Pages 41-46

  Hubert, Julien ^a   Thiboutot, Eva ^a   Dubé, Pierre ^a   Cloutier, Alexis Simon ^a   Drolet, Pierre ^a   Sideris, Lucas ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

Hyperthermic intraperitoneal chemotherapy; Oxaliplatin; Peritoneal mesothelioma; Peritoneal neoplasms

Indexed keywords

ANTIBIOTIC AGENT; CISPLATIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; MITOMYCIN; OXALIPLATIN; PEMETREXED; OXIPLATIN; PLATINUM COMPLEX; PYRIDINE DERIVATIVE;

ABDOMINAL ABSCESS; ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL ARTICLE; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEMATOMA; HUMAN; MALE; OVERALL SURVIVAL; PERITONEUM MESOTHELIOMA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; FACTUAL DATABASE; HYPERTHERMIC THERAPY; INFUSION; MESOTHELIOMA; MIDDLE AGED; PATHOLOGY; PERITONEAL NEOPLASMS; SURVIVAL;

ADULT; AGED; CYTOREDUCTION SURGICAL PROCEDURES; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; MALE; MESOTHELIOMA; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; PERITONEAL NEOPLASMS; PYRIDINES; SURVIVAL ANALYSIS;

EID: 84925947265     PISSN: 09607404     EISSN: 18793320     Source Type: Journal    
DOI: 10.1016/j.suronc.2014.12.002     Document Type: Review

References (40)

1. P.A. Clavien, J. Barkun, M.L. de Oliveira, J.N. Vauthey, D. Dindo, and R.D. Schulick et al. The Clavien-Dindo classification of surgical complications: five-year experience Ann Surg 250 2 2009 187 196
2. G. Sebbag, H. Yan, B.M. Shmookler, D. Chang, and P.H. Sugarbaker Results of treatment of 33 patients with peritoneal mesothelioma Br J Surg 87 11 2000 1587 1593
3. B. Price Analysis of current trends in United States mesothelioma incidence Am J Epidemiol 145 3 1997 211 218
4. Y.I. Acherman, L.S. Welch, C.M. Bromley, and P.H. Sugarbaker Clinical presentation of peritoneal mesothelioma Tumori 89 3 2003 269 273
5. L.S. Welch, Y.I. Acherman, E. Haile, R.K. Sokas, and P.H. Sugarbaker Asbestos and peritoneal mesothelioma among college-educated men Int J Occup Environ Health 11 3 2005 254 258
6. J.C. Wagner, C. Sleggs, and P. Marchand Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province Br J Ind Med 17 2005 260 271
7. T.D. Yan, L. Welch, D. Black, and P.H. Sugarbaker A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma Ann Oncol 18 5 2007 827 834
8. A.P. Chahinian, T.F. Pajak, J.F. Holland, L. Norton, R.M. Ambinder, and E.M. Mandel Diffuse malignant mesothelioma. Prospective evaluation of 69 patients Ann Intern Med 96 6 Pt 1 1982 746 755
9. R.H. Riddell, M.J. Goodman, and A.R. Moossa Peritoneal malignant mesothelioma in a patient with recurrent peritonitis Cancer 48 1 1981 134 139
10. J.T. Peterson Jr., S.D. Greenberg, and P.A. Buffler Non-asbestos-related malignant mesothelioma. A review Cancer 54 5 1984 951 960
11. D. Baratti, S. Kusamura, D. Nonaka, G.D. Oliva, B. Laterza, and M. Deraco Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC) Ann Surg Oncol 14 10 2007 2790 2797
12. D. Baratti, S. Kusamura, A. Sironi, A. Cabras, L. Fumagalli, and B. Laterza et al. Multicystic peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC) In Vivo 22 1 2008 153 157
13. D. Baratti, M. Vaira, S. Kusamura, S. D'Amico, M.R. Balestra, and T. Cioppa et al. Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) Eur J Surg Oncol 36 11 2010 1047 1053
14. T.D. Yan, M. Deraco, D. Baratti, S. Kusamura, D. Elias, and O. Glehen et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience J Clin Oncol 27 36 2009 6237 6242
15. A.L. Feldman, S.K. Libutti, J.F. Pingpank, D.L. Bartlett, T.H. Beresnev, and S.M. Mavroukakis et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy J Clin Oncol 21 24 2003 4560 4567
16. G. Passot, E. Cotte, C. Brigand, A.C. Beaujard, S. Isaac, and F.N. Gilly et al. Peritoneal mesothelioma: treatment with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy J Chir Paris 145 5 2008 447 453
17. D. Elias, M. Bonnay, J.M. Puizillou, S. Antoun, S. Demirdjian, and O.A. El et al. Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution Ann Oncol 13 2 2002 267 272
18. D. Elias, T. Matsuhisa, L. Sideris, G. Liberale, L. Drouard-Troalen, and B. Raynard et al. Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance Ann Oncol 15 10 2004 1558 1565
19. D. Elias, V. Bedard, T. Bouzid, P. Duvillard, N. Kohneh-Sharhi, and B. Raynard et al. Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy Gastroenterol Clin Biol 31 10 2007 784 788
20. D. Elias, M. Pocard, L. Sideris, C. Ede, M. Ducreux, and V. Boige et al. Rationale for heating oxaliplatin for the intraperitoneal treatment of peritoneal carcinomatosis: a study of the effect of heat on intraperitoneal oxaliplatin using a murine model Ann Surg 254 1 2011 138 144
21. D. Elias et al. Preliminary results of intraperitoneal chemohyperthermia with oxaliplatin in peritoneal carcinomatosis of colorectal origin Br J Surg 91 4 2004 455 456
22. D. Elias, M. Pocard, and D. Goere HIPEC with oxaliplatin in the treatment of peritoneal carcinomatosis of colorectal origin Cancer Treat Res 134 2007 303 318
23. D. Elias, J.H. Lefevre, J. Chevalier, A. Brouquet, F. Marchal, and J.M. Classe et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin J Clin Oncol 27 5 2009 681 685
24. D. Hompes, A. D'Hoore, E. Van Cutsem, S. Fieuws, W. Ceelen, and M. Peeters et al. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study Ann Surg Oncol 19 7 2012 2186 2194
25. F. Mohamed, T. Cecil, B. Moran, and P. Sugarbaker A new standard of care for the management of peritoneal surface malignancy Curr Oncol 2 2011 e84 e96
26. S.W. Weiss World health organization International histological classification of tumours. Histological typing of soft tissue tumours 2nd Edition 1994 Springer-Verlag Berlin
27. P.H. Sugarbaker Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis Semin Surg Oncol 14 3 1998 254 261
28. O. Glehen, and F.N. Gilly Quantitative prognostic indicators of peritoneal surface malignancy: carcinomatosis, sarcomatosis, and peritoneal mesothelioma Surg Oncol Clin N Am 12 2003 649 671
29. K.S. Sridhar, R. Doria, W.A. Raub Jr., R.J. Thurer, and M. Saldana New strategies are needed in diffuse malignant mesothelioma Cancer 70 12 1992 2969 2979
30. M. Markman, and D. Kelsen Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma J Cancer Res Clin Oncol 118 7 1992 547 550
31. D.H. Yates, B. Corrin, P.N. Stidolph, and K. Browne Malignant mesothelioma in south east England: clinicopathological experience of 272 cases Thorax 52 6 1997 507 512
32. V. Neumann, K.M. Muller, and M. Fischer Peritoneal mesothelioma-incidence and etiology Pathologe 20 3 1999 169 176
33. G.H. Eltabbakh, M.S. Piver, R.E. Hempling, F.O. Recio, and M.E. Intengen et al. Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma J Surg Oncol 70 1 1999 6 12
34. D. Elias, L. Sideris, M. Pocard, C. è, D. Ben Hassouna, and M. Ducreux et al. Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Prelim results 24 patients Ann Oncol 15 5 2004 781 785
35. P.H. Sugarbaker, T.D. Yan, O.A. Stuart, and D. Yoo Comprehensive management of diffuse malignant peritoneal mesothelioma Eur J Surg Oncol 32 6 2006 686 691
36. Faheez Mohamed, Kaiumarz Sethna, Dominique Elias, and Paul H. Sugarbaker Challenging and unusual cases: case 3. Peritoneal cystic mesothelioma J Clin Oncol 21 7 2003 1419 1420
37. S. González-Moreno, H. Yan, K.W. Alcorn, and P.H. Sugarbaker Malignant transformation of "benign" cystic mesothelioma of the peritoneum J Surg Oncol 79 4 2002 243 251
38. D.B. DeStephano, J.R. Wesley, K.P. Heidelberger, R.J. Hutchinson, C.E. Blane, and A.G. Coran Primitive cystic hepatic neoplasm of infancy with mesothelial differentiation: report of a case Pediatr Pathol 4 3-4 1985 291 302
39. T.C. Chua, T.D. Yan, M. Deraco, O. Glehen, B.J. Moran, and P.H. Sugarbaker Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma Br J Surg 98 1 2011 60 64
40. C. Brigand, O. Monneuse, F. Mohamed, A.C. Sayag-Beaujard, S. Isaac, and F.N. Gilly et al. Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study Ann Surg Oncol 13 3 2006 405 412